ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2020

Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!

Binita Dutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.